Development and External Testing of an Interpretable MRI-Based Machine Learning Model for Differentiating Endometrial Stromal Sarcoma from Cellular Leiomyoma
- 13 October 2026
- journal article
- research article
- Published by Springer Nature in Journal of Imaging Informatics in Medicine
- p. 1-12
Abstract
This retrospective two-center diagnostic study was aimed at developing and externally testing an interpretable MRI-based machine learning model for differentiating endometrial stromal sarcoma (ESS) from cellular leiomyoma (CL). A total of 155 women with pathologically confirmed ESS or CL were assigned to a derivation cohort (n = 111) and an external testing cohort (n = 44). Clinical variables, qualitative MRI features, and apparent diffusion coefficient (ADC) histogram parameters were evaluated. Three MRI-derived predictors—irregular tumor margin, cystic areas on T2-weighted imaging, and mean ADC—were used to train six classifiers. The final support vector machine model with a radial basis function kernel was evaluated at a fixed threshold determined in the derivation cohort using receiver operating characteristic, calibration, decision curve, and Shapley additive explanations (SHAP) analyses. A reader study assessed the effect of model assistance. The model achieved areas under the curve of 0.843 (95% CI, 0.760–0.917) in the derivation cohort and 0.835 (95% CI, 0.669–0.960) in the external testing cohort. Calibration and decision curve analyses indicated acceptable performance and potential clinical utility. In an exploratory model-assisted reader analysis, junior radiologist specificity increased from 46.4 to 82.1% and accuracy from 52.3 to 77.3%. This interpretable three-feature model demonstrated promising performance across cohorts and may serve as an adjunctive tool for preoperative MRI assessment, although prospective multicenter validation is warranted.Keywords
Funding Information
- Science and Technology Commission of Shanghai Municipality (Project No. 25ZR1401036)
- Shanghai Pudong New Area Health Commission (Project No.: PWZbr2022-16)
This publication has 35 references indexed in Scilit:
- The value of multiparametric MRI-based habitat imaging for differentiating uterine sarcomas from atypical leiomyomas: a multicentre studyAbdominal Radiology, 2024
- MRI, clinical, and radiomic models for differentiation of uterine leiomyosarcoma and leiomyomaAbdominal Radiology, 2024
- T2 hyperintense myometrial tumors: can MRI features differentiate leiomyomas from leiomyosarcomas?Abdominal Radiology, 2019
- MRI screening for uterine leiomyosarcomaJournal of Magnetic Resonance Imaging, 2019
- Magnetic resonance imaging features of uterine sarcoma and mimickersAbdominal Radiology, 2017
- Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture AnalysisEuropean Radiology, 2016
- Comparison of the diagnostic accuracy of contrast‐enhanced MRI and diffusion‐weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyomaJournal of Magnetic Resonance Imaging, 2015
- How to differentiate benign from malignant myometrial tumours using MR imagingEuropean Radiology, 2013
- Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomasEuropean Radiology, 2009
- The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomasEuropean Radiology, 2007